/
•
•
Inadequately trained staff pretending to be dentists and poor after-sales services have plagued the five-year-old health-tech startup.

The 15-year-old company has bought one brand after another in the hope of growing fast. That plan has fallen flat on its face, but there’s no stopping Wingreens.
The managing partner at Key Capital talks about his new—and the region’s first-ever—secondaries fund and why long investment cycles are not everyone’s cup of tea.
The Mideast tech giant is scaling back verticals in Saudi Arabia and possibly rethinking global operations.